0001209191-23-018012.txt : 20230310 0001209191-23-018012.hdr.sgml : 20230310 20230310195052 ACCESSION NUMBER: 0001209191-23-018012 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Detheux Michel CENTRAL INDEX KEY: 0001816196 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 23725337 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET STREET 2: BLDG 312, FLOOR 3, SUITE 301 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 321 ARSENAL STREET STREET 2: BLDG 312, FLOOR 3, SUITE 301 CITY: WATERTOWN STATE: MA ZIP: 02472 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2022-12-31 0 0 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816196 Detheux Michel 321 ARSENAL STREET WATERTOWN MA 02472 0 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 36.21 2022-04-15 5 G 0 L 264375 0.00 D 2032-03-11 Common Stock 264375 88125 D Stock Option (Right to Buy) 36.21 2022-04-15 5 G 0 L 264375 0.00 A 2032-03-11 Common Stock 264375 264375 I By MG3A The reporting person transferred these stock options to MG3A, a Belgian partnership of which the reporting person is the manager and the reporting person's spouse is the successor manager. This stock option vests over four years, with 25% vesting on March 11, 2023 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Issuer. /s/ Adi Osovsky, as Attorney-in-Fact 2023-03-10